Bloomberg Businessweek cover image

Medicare May Cover Weight-Loss Drug Wegovy

Bloomberg Businessweek

00:00

Exploring the Expanded Healthcare Potential of a Weight-Loss Drug

This chapter explores the wide-ranging health benefits of a weight-loss drug beyond its primary function, while grappling with the ethical and financial implications of its widespread use. Discussions include Medicare's consideration of covering the drug for its heart benefits, concerns over taxpayer funding, and the challenges of combatting obesity comprehensively.

Play episode from 04:46
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app